At the news
? NEUTRALIMPACT 2/10 144 filed Oct 8, 2026 at 17:46 ET
Scott Cutler, CEO of HealthEquity, filed a Form 144 on October 8, 2026, indicating intent to sell 1,230 shares of common stock. The sale is mandated by a 'sell to cover' tax withholding obligation under the company's equity incentive plan, not a discretionary trade. The proposed sale value is approximately $112,121 based on the recent market price.
- Insider: Scott Cutler (CEO and Director)
- Proposed sale: 1,230 shares of common stock
- Estimated value: ~$112,121 (based on ~$91.16/share recent price)
- Reason: Mandatory 'sell to cover' tax withholding, not discretionary
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access